RTI Biologics, Inc. process human musculoskeletal and other tissue. It also processes bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine animal tissue in producing allograft and xenograft implants utilizing BIOCLEANSE and TUTOPLAST sterilization processes, for distribution to hospitals and surgeons. It process at two facilities in Alachua, Florida and one facility in Neunkirchen, Germany and distributes its products and services in all 50 states and in over 30 countries worldwide. The Company processs human and bovine animal tissue and distribute the tissue through various distribution channels. Its lines of business are consists primarily of five product categories: sports medicine, spine, dental, surgical specialties, Bone graft substitutes (BGS) and general orthopedic.